Biology:Combined oxidative phosphorylation defect type 17

From HandWiki
Short description: Genetic disorder


Combined oxidative phosphorylation deficiency-17 (COXPD17) is a very rare autosomal recessive mitochondrial disease characterized primarily by onset of severe hypertrophic cardiomyopathy in the first year of life.[1][2][3]

Causes and inheritance

COXPD17 is caused by homozygous or compound heterozygous mutations in the ELAC2 gene that functions as a mitochondrial tRNA processing gene.[1][3]

It follows an autosomal recessive inheritance pattern,[1][2][3] which means:[4][5]

Individuals with one mutated copy (heterozygous carriers) are typically asymptomatic and do not show clinical features of the disease.[4][5]

When both parents are carriers, their children have:[4][5]

  • 25% (1 in 4) chance of being affected.
  • 50% (2 in 4) chance of being asymptomatic carriers.
  • 25% (1 in 4) chance of not inheriting the mutation.

Symptoms

Symptoms of COXPD17 include:[1]

Onset

The disorder presents during early infancy, with hypertrophic cardiomyopathy appearing within the first months of life. It may be fatal in early childhood.[1]

References